Deciphera Pharmaceuticals (DCPH) Insider Trading & Ownership → Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad) Free DCPH Stock Alerts $25.38 +0.01 (+0.04%) (As of 05/7/2024 ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Deciphera Pharmaceuticals (NASDAQ:DCPH) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage4.43%Number OfInsiders Buying(Last 12 Months)2Amount OfInsider Buying(Last 12 Months)$291,260.00Number OfInsiders Selling(Last 12 Months)4Amount OfInsider Selling(Last 12 Months)$470,122.61 Get DCPH Insider Trade Alerts Want to know when executives and insiders are buying or selling Deciphera Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address DCPH Insider Buying and Selling by Quarter Ad Colonial MetalsThe asset beating inflation by 4x"Trump Loophole" Beats Inflation? Inflation has been out of control for years. Forcing you to work longer and harder for more money that is worth less. By using the "Trump Loophole", you can use a special retirement account to buy gold — and other precious metals — without taxes or penalties.That's why we have released our Free Precious Metals Investment Guide that explains all the details Deciphera Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails1/16/2024Jama PitmanSVPSell1,624$14.47$23,499.28 1/16/2024Matthew L ShermanEVPSell2,435$14.47$35,234.45 10/30/2023Jama PitmanInsiderSell1,407$12.02$16,912.14 10/30/2023Matthew L ShermanEVPSell2,360$12.02$28,367.20 10/30/2023Steven L HoerterCEOSell21,573$12.02$259,307.46 10/30/2023Thomas Patrick KellyCFOSell2,316$12.02$27,838.32 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 10/2/2023Matthew L ShermanEVPSell2,942$12.68$37,304.56 6/16/2023Jama PitmanInsiderSell1,238$14.40$17,827.20 6/16/2023Matthew L ShermanEVPSell1,655$14.40$23,832.00 6/8/2023Franklin Stuart FriedmanDirectorBuy10,000$13.88$138,800.00 5/10/2023Dennis Leo WalshDirectorBuy11,000$13.86$152,460.00 (Data available from 1/1/2013 forward) DCPH Insider Trading Activity - Frequently Asked Questions Who is on Deciphera Pharmaceuticals's Insider Roster? The list of insiders at Deciphera Pharmaceuticals includes Brightstar Associates Llc, Daniel C Martin, Daniel Lee Flynn, Dennis Leo Walsh, Franklin Stuart Friedman, Jama Pitman, Matthew L Sherman, Steven L Hoerter, and Thomas Patrick Kelly. Learn more on insiders at DCPH. What percentage of Deciphera Pharmaceuticals stock is owned by insiders? 4.43% of Deciphera Pharmaceuticals stock is owned by insiders. Learn more on DCPH's insider holdings. Which Deciphera Pharmaceuticals insiders have been buying company stock? The following insiders have purchased DCPH shares in the last 24 months: Brightstar Associates Llc ($29,999,988.00), Dennis Leo Walsh ($152,460.00), and Franklin Stuart Friedman ($138,800.00). How much insider buying is happening at Deciphera Pharmaceuticals? Insiders have purchased a total of 1,687,666 DCPH shares in the last 24 months for a total of $30,291,248.00 bought. Which Deciphera Pharmaceuticals insiders have been selling company stock? The following insiders have sold DCPH shares in the last 24 months: Daniel C Martin ($17,500.90), Daniel Lee Flynn ($51,039.72), Jama Pitman ($72,192.12), Matthew L Sherman ($206,860.82), Steven L Hoerter ($259,307.46), and Thomas Patrick Kelly ($48,525.32). How much insider selling is happening at Deciphera Pharmaceuticals? Insiders have sold a total of 56,606 Deciphera Pharmaceuticals shares in the last 24 months for a total of $772,201.34 sold. More Insider Trading Tools from MarketBeat Related Companies: MRVI Insider Trading TGTX Insider Trading KROS Insider Trading AMPH Insider Trading GERN Insider Trading VERA Insider Trading ARVN Insider Trading DYN Insider Trading RCKT Insider Trading NAMS Insider Trading Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: 3 Penny Stocks That Insiders Are BuyingThe 3 Hottest Insiders Buys This Month 3 Companies Buying Back Cheap Stock LatelyPagaya Technologies: An AI Fintech That Insiders Are BuyingThe 5 Stocks Most Sold By Insiders This Year This page (NASDAQ:DCPH) was last updated on 5/7/2024 by MarketBeat.com Staff From Our PartnersThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorThe A.I. story nobody is telling you (Read ASAP)TradeSmithConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsElon Musk Secret Crypto Plot ExposedCrypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsObama’s Forever Term [exposed]Porter & CompanyThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsPOTUS in ‘25 Not Biden/Trump, ButThe Freeport Society Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Deciphera Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.